Ahmed Badheeb Omar Alkhanbashi Slah Rakrouki Tahir Mahmood Mashhoor Alqannas Mohamed Badheeb Faisal Ahmed
10.11604/pamj.2022.42.98.33911
Pan Afr Med J
2022 Jun 7;42:98.
perforation bladder cancer case report pembrolizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36034031/
Antineoplastic Agents, Immunological Carcinoma, Transitional Cell Urinary Bladder Diseases Urinary Bladder Neoplasms
Antineoplastic Agents, Immunological Carcinoma, Transitional Cell Urinary Bladder Diseases Urinary Bladder Neoplasms Case Reports Aged Antibodies, Monoclonal, Humanized Humans Immunologic Factors Immunotherapy Male Urinary Bladder Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological Immunologic Factors pembrolizumab
PMC9379440
36034031
Bladder rupture after pembrolizumab immunotherapy for bladder cancer: a case report
2022